By Sabela Ojea
The Food and Drug Administration has granted marketing authorization for Masimo Corp.’s anti-opioid-overdosing device.
The Masimo SafetyNet Opioid System is a monitoring device that responds to potential respiratory depression due to opioid use or overdose.
The device uses software that can notify personal contacts or an emergency medical service dispatch to help ensure the person using opioids receives treatment intervention.
It can be used in a hospital or in-home setting by those taking prescribed opioid medications or using opioids illicitly.
On Wednesday, the FDA said the overdose-reversal medication Narcan could be sold over the counter for the first time since the opioid crisis began.
Narcan’s manufacturer, Emergent BioSolutions Inc., said the nasal-spray version of the medication naloxone would likely begin appearing on shelves by late summer .
Write to Sabela Ojea at [email protected]; @sabelaojeaguix
Read the full article here